This report provides a current epidemiological update on the intensity and severity of COVID-19 in Manitoba. Surveillance and administrative data include laboratory, public health case and contact tracing investigations, hospitalization and mortality data. Data are presented at the provincial and regional level; and include a focussed review on the disproportional impact of COVID-19 on various populations in the province.
In this weekly respiratory surveillance report, we provide regular updates about the current activity of COVID-19 in Manitoba with overall objectives:
Data are reported with a one-week delay for increased data accuracy, completeness and reliability. More analyses continue to be conducted and will be added to this report as available. It is published online at approximately 10:00am every Monday.
Reporting for seasonal influenza in 2021-2022 season will start on October 29, 2021 for Week 42 (October 17–23, 2021).
Data extracted up to 4:00 am on October 15, 2021
Next reporting date: October 25, 2021
|
||||||||||||||||||
|
|
|
||||||||||||||||
|
|
|
||||||||||||||||
Important Notes
|
Note. Deaths due to COVID-19 were aligned by week of death date.
Back
Health Region | Cases | Percentage |
---|---|---|
Winnipeg RHA | 35039 | 56.9% |
Southern Health-Santé Sud | 8985 | 14.6% |
Interlake-Eastern RHA | 4584 | 7.4% |
Prairie Mountain Health | 4477 | 7.3% |
Northern Health Region | 8508 | 13.8% |
Note: Unprotected Case: Individuals vaccinated 0–13 days following the first dose of a COVID-19 vaccine. Partially Vaccinated Case: Individuals vaccinated >=14 days following the first dose of a 2-dose series COVID-19 vaccine if only one dose was received and 0-13 days following the second dose if two doses were received. Fully Vaccinated Case: Individuals vaccinated >=14 days following the second dose of a 2-dose series or first dose of a 1-dose series of a COVID-19 vaccine.
Partially vaccinated | % | Fully vaccinated | % | |
---|---|---|---|---|
Table 2a. COVID-19 Cases After Vaccination, Overall | ||||
AZ/COVISHIELD | 417 | 18.0% | 12 | 0.9% |
Janssen | N/A | N/A | 5 | 0.4% |
Moderna | 508 | 21.9% | 417 | 31.2% |
Pfizer | 1,394 | 60.1% | 709 | 53.1% |
Mixed vaccine products | N/A | N/A | 190 | 14.2% |
Total | 2,319 | 100% | 1,335 | 100% |
Table 2b. COVID-19 Cases After Vaccination by Age Group | ||||
12-19 | 122 | 5.3% | 80 | 6.0% |
20-29 | 254 | 11.0% | 185 | 13.9% |
30-39 | 284 | 12.2% | 245 | 18.4% |
40-49 | 343 | 14.8% | 215 | 16.1% |
50-59 | 454 | 19.6% | 194 | 14.5% |
60-69 | 447 | 19.3% | 195 | 14.6% |
70-79 | 250 | 10.8% | 115 | 8.6% |
80+ | 165 | 7.1% | 106 | 7.9% |
Total | 2,319 | 100% | 1,335 | 100% |
Table 2c. Severe COVID-19 Cases After Vaccination | ||||
Hospitalizations (including ICU admissions) | ||||
12-19 | 1 | 0.5% | 3 | 3.2% |
20-29 | 12 | 5.4% | 3 | 3.2% |
30-39 | 10 | 4.5% | 6 | 6.4% |
40-49 | 13 | 5.9% | 2 | 2.1% |
50-59 | 34 | 15.3% | 9 | 9.6% |
60-69 | 46 | 20.7% | 23 | 24.5% |
70+ | 106 | 47.7% | 48 | 51.1% |
Total hospitalizations | 222 | 100% | 94 | 100% |
Deaths | ||||
12-19 | 0 | 0.0% | 0 | 0.5% |
20-29 | 0 | 0.0% | 0 | 5.4% |
30-39 | 0 | 0.0% | 0 | 4.5% |
40-49 | 0 | 0.0% | 0 | 5.9% |
50-59 | 7 | 15.6% | 0 | 15.3% |
60-69 | 9 | 20.0% | 6 | 20.7% |
70+ | 29 | 64.4% | 15 | 47.7% |
Total deaths | 45 | 100% | 21 | 100% |
Table 2d. COVID-19 Cases After Vaccination by Sex | ||||
Infections in females | 1,240 | 53.5% | 749 | 56.1% |
Infections in males | 1,079 | 46.5% | 586 | 43.9% |
Total | 2,319 | 100% | 1,335 | 100% |
Table 2e. COVID-19 Cases After Vaccination by VOC | ||||
B.1.1.7 - Alpha | 538 | 23.2% | 80 | 6.0% |
B.1.6.1.7.2 - Delta | 163 | 7.0% | 192 | 14.4% |
Other | 37 | 1.6% | 10 | 0.7% |
Unspecified | 801 | 34.5% | 631 | 47.3% |
Non-VOC | 780 | 33.6% | 422 | 31.6% |
Total | 2,319 | 100% | 1,335 | 100% |
Note. Other VOCs include AY.3 (Delta Plus), B.1.351 (Beta), B.1.617, B.1.617.2 (Kappa), and P.1 (Gamma).
Province | Confirmed Cases | Tests Completed | Test Rate in Population (Estimated %) | Positivity Rate (Estimated %) |
---|---|---|---|---|
Alberta | 308,275 | 5,610,443 | 128.9% | 5.5% |
British Columbia | 192,491 | 3,931,735 | 77.9% | 4.9% |
Manitoba | 61,372 | 1,076,629 | 78.9% | 5.7% |
New Brunswick | 4,987 | 492,730 | 63.7% | 1.0% |
Newfoundland and Labrador | 1,848 | 368,320 | 70.4% | 0.5% |
Northwest Territories | 1,411 | 33,176 | 73.9% | 4.3% |
Nova Scotia | 6,918 | 1,245,774 | 128.9% | 0.6% |
Nunavut | 666 | 20,988 | 54.3% | 3.2% |
Ontario | 590,677 | 18,166,272 | 125.4% | 3.3% |
Prince Edward Island | 306 | 206,222 | 132.5% | 0.1% |
Quebec | 414,573 | 11,865,818 | 140.5% | 3.5% |
Saskatchewan | 71,034 | 1,158,744 | 99.0% | 6.1% |
Yukon | 793 | 9,129 | 22.5% | 8.7% |
Canada | 1,655,364 | 44,186,056 | 118.1% | 3.7% |
Note. National testing data are collected daily from the national Coronavirus disease (COVID-19) Outbreak update webpage.
Note. ICU admissions are not included in the hospital admissions.
Note. Musculoskeletal illnesses include: osteoporosis, osteoarthritis, juvenile idiopathic arthritis, gout and crystal Arthropathies; COPD-chronic obstructive pulmonary disease; CVD-cardiovascular disease; Other CVDs include: ischemic heart disease, heart failure, acute myocardial infarction, and stroke; Other chronic conditions include: parkinson’s disease, multiple sclerosis, alzheimer’s disease and epilepsy. About definitions of chronic conditions
Source of Infection | Cases | Percentage |
---|---|---|
Close contact of known case | 1574 | 57.4% |
Pending | 208 | 7.6% |
Travel | 36 | 1.3% |
Unknown | 924 | 33.7% |
All Cases | 2742 |
Role | Cases | Percentage |
---|---|---|
Allied Health, Health Professionals, and Support Staff | 1676 | 61.1% |
Nurse/Licensed Practical Nurse | 697 | 25.4% |
Not identified | 219 | 8% |
Physician/Physician in training | 92 | 3.4% |
First Responder | 58 | 2.1% |
All Cases | 2742 |
Regional Health Authority | Cases | Median Contacts | Minimum Contacts | Maximum Contacts |
---|---|---|---|---|
Winnipeg Health | 35039 | 3 | 0 | 249 |
Southern Health - Sante Sud | 8985 | 2 | 0 | 69 |
Northern Health | 8508 | 1 | 0 | 121 |
Interlake-Eastern Health | 4584 | 2 | 0 | 76 |
Prairie Mountain Health | 4477 | 3 | 0 | 134 |
Regional Health Authority | Cases | Median Contacts | Minimum Contacts | Maximum Contacts |
---|---|---|---|---|
Southern Health - Sante Sud | 227 | 3 | 0 | 30 |
Northern Health | 159 | 0 | 0 | 9 |
Winnipeg Health | 157 | 3 | 0 | 53 |
Prairie Mountain Health | 126 | 5 | 0 | 33 |
Interlake-Eastern Health | 55 | 0 | 0 | 18 |
Note: COVID-19 public health orders in Manitoba since January 23, 2021: PH order #1 (effective January 23, 2021), PH order #2 (effective March 5, 2021), PH order #3 (effective March 26, 2021), PH order #4 (effective April 19, 2021), PH order #5 (effective April 28, 2021), PH order #6 (effective May 9, 2021), PH order #7 (effective May 22, 2021), PH order #8 (effective May 29, 2021), PH order #9 (effective June 12, 2021), PH order #10 (effective June 26, 2021), PH order #11: (effective July 17, 2021), PH order #12: (effective August 7, 2021), PH order #13: (effective August 28, 2021), PH order #14: (effective October 5, 2021). Content of Public Health Orders
Note: COVID-19 public health orders in Manitoba since January 23, 2021: PH order #1 (effective January 23, 2021), PH order #2 (effective March 5, 2021), PH order #3 (effective March 26, 2021), PH order #4 (effective April 19, 2021), PH order #5 (effective April 28, 2021), PH order #6 (effective May 9, 2021), PH order #7 (effective May 22, 2021), PH order #8 (effective May 29, 2021), PH order #9 (effective June 12, 2021), PH order #10 (effective June 26, 2021), PH order #11: (effective July 17, 2021), PH order #12: (effective August 7, 2021), PH order #13: (effective August 28, 2021), PH order #14: (effective October 5, 2021). Content of Public Health Orders
Note: COVID-19 public health orders in Manitoba since January 23, 2021: PH order #1 (effective January 23, 2021), PH order #2 (effective March 5, 2021), PH order #3 (effective March 26, 2021), PH order #4 (effective April 19, 2021), PH order #5 (effective April 28, 2021), PH order #6 (effective May 9, 2021), PH order #7 (effective May 22, 2021), PH order #8 (effective May 29, 2021), PH order #9 (effective June 12, 2021), PH order #10 (effective June 26, 2021), PH order #11: (effective July 17, 2021), PH order #12: (effective August 7, 2021), PH order #13: (effective August 28, 2021), PH order #14: (effective October 5, 2021). Content of Public Health Orders
Note: Other symptoms include those less common symptoms such as sweating, runny eyes, itchy throat, etc.